Facebook
Twitter
LinkedIn
ForwardMiami Cancer Institute Women’s Cancer Symposium, Second Annual
Live Virtual Symposium - April 16, 2021
The Miami Cancer Institute Women’s Cancer Symposium brings together a distinguished faculty for a one-day virtual symposium that will focus on the medical management of common and important challenges facing health-care professionals who care for women with cancer. The multispecialty approach allows participants to explore new diagnoses and cutting-edge treatment options for various areas of breast and ovarian cancer patient care in a concise symposium format.
Miami Cancer Institute Launches Breast Cancer Prevention Clinic
Physicians and other medical professionals at Miami Cancer Institute are as focused on providing lifesaving treatments for women with breast cancer as they are dedicated to preventing the disease.
Learning Objectives
Upon completion of this conference, participants should be better able to:
- Identify and explain the latest trends in research and technology in the treatment of gynecologic and breast cancers.
- Interpret contemporary research findings and be able to appropriately implement changes into clinical practice.
- Examine the significance of novel approaches to the medical and surgical management of breast and gynecologic cancers within the context of the current standard of care.
- Integrate new gynecologic oncology therapies into clinical practice in an evidence-based manner.
- Amplify implementation of novel approaches to the clinical care team.
- Assess the implications for future directions in research and clinical practice in breast and gynecologic cancers.
Agenda
| 7:45 - 8:00 a.m | Introductions Gladys Giron, M.D. Opening Remarks: Miami Cancer Institute: Impact on Cancer Care in South Florida Michael Zinner, M.D. |
| MODERATOR: Jane Mendez, M.D. | |
| 8:00-8:20 a.m. | Building a Research Consortium Paul Sabbatini, M.D. |
| 8:20 - 8:45 a.m. | De-escalation of Chemotherapy for Early Stage Breast Cancers Rachel Sanford, M.D. |
| 8:45 - 9:05 a.m. | Advances in Cardio-oncology in Cancer Treatment Ranju Gupta, M.D. |
| 9:05 - 9:25 a.m. | Updates on the Management of Metastatic Breast Cancer Ana C. Sandoval Leon, M.D. |
| 9:25 - 9:35 a.m. | Break |
| MODERATOR: Starr Mautner, M.D. | |
| 9:35 - 10:00 a.m. | Contrast-enhanced Spectral Mammography Kathy J. Schilling, M.D. |
| 10:00 - 10:25 a.m. | Update on Breast Cancer Prevention Options and RISE Program Melissa Pilewskie, M.D. |
| 10:25 - 10:45 a.m. | Advances in Oncoplastic Techniques in Breast Reduction Harry Salinas, M.D. |
| 10:45 - 11:10 a.m. | External Beam Partial Breast Irradiation and MSK 19-300 Alliance Trial Erin Gillespie, M.D. |
| 11:10 a.m. - 11:55 a.m. | Lunch |
| MODERATOR: Gladys Giron, M.D. | |
| 12:00 - 12:20 p.m. | Sexual Health and Cancer Jeanne Carter, Ph.D. |
| 12:20 - 12:40 p.m. | Standards for Germline Testing for Hereditary Breast and Ovarian Carcinoma Upon Diagnosis- A Rapidly Moving Target Daniel Morganstern, M.D. |
| 12:40 - 1:00 p.m. | The Role of Integrative Medicine in Breast and Gynecologic Cancers Ting Bao, M.D. |
| 1:00 - 1:10 p.m. | Break |
| MODERATOR: John Diaz, M.D. | |
| 1:10 -1:35 p.m. | Surgical Management of High-risk Endometrial Cancer: Should Sentinel Lymph Node be the Standard Ginger Gardner, M.D. |
| 1:35 - 1:55 p.m. | Immunotherapy in the Management of Endometrial Cancer Shannon Westin, M.D. |
| 1:55 - 2:20 p.m. | Developing Strategies to Prevent Gynecologic Cancers Martin A. Martino, M.D. |
| 2:20-2:30 p.m. | Break |
| MODERATOR: Nicholas Lambrou, M.D. | |
| 2:30-2:50 p.m. | The Role of Hyperthermic Intraperitoneal Chemotherapy in the Management of Ovarian Cancer Oliver Zivanovic, M.D. |
| 2:50-3:15 p.m. | Maintenance Therapy for Newly Diagnosed Ovarian Cancer: PARP Inhibitors, Bevacizumab, or Both? (or Perhaps Neither) Jason Konner, M.D. |
| 3:15 p.m. | Closing Remarks John Diaz, M.D. |
| 3:25p.m. | Adjourn |
NOTE: Schedule subject to change.
Symposium Directors
 | John P. Diaz, M.D., FACOG Deputy Chief of Gynecologic Oncology Lead Physician for Clinical Trials in Gynecologic Oncology Miami Cancer Institute Chief, Center of Excellence in Minimally Invasive Gynecologic Surgery Baptist Health South Florida |
 | Gladys L. Giron, M.D., FACS Breast Surgical Oncology Cancer Liaison Physician Miami Cancer Institute |
 | Nicholas C. Lambrou, M.D., FACOG Chief of Gynecologic Oncology, Miami Cancer Institute Director of Robotic Surgery, Baptist Health South Florida Associate Professor, Herbert Wertheim College of Medicine Florida International University |
 | Starr K. Mautner, M.D., FACS Breast Surgical Oncology Cancer Liaison Physician Miami Cancer Institute |
Faculty
 | Ting Bao, M.D. Director of Integrative Breast Oncology Memorial Sloan Kettering Cancer Center New York, New York |
 | Jeanne Carter, Ph.D. Head, Female Sexual Medicine and Women's Health Program Gynecology Service, Department of Surgery Memorial Sloan Kettering Cancer Center New York, New York |
 | Ginger J. Gardner, M.D., FACOG Section, Ovarian Cancer Surgery; Physician Lead, Gynecology Disease Management Team Alliance; Vice Chair of Hospital Operations, Department of Surgery Memorial Sloan Kettering Cancer Center New York, New York |
 | Erin Gillespie, M.D. Assistant Attending Radiation Oncologist Memorial Sloan Kettering Cancer Center New York, New York |
 | Ranju Gupta, M.D. Attending Physician, Breast Medical Oncologist Cancer Institute Lehigh Valley Health Network Bethlehem, Pennsylvania |
 | Jason A. Konner, M.D. Director, GMO New Jersey Gynecologic Medical Oncology & Early Drug Development Clinical Member, Memorial Hospital Memorial Sloan Kettering Cancer Center New York, New York |
 | Martin A. Martino, M.D. Professor University of South Florida College of Medicine, Department of ObGyn |
 | Jane E. Mendez, M.D. Chief, Breast Surgery Miami Cancer Institute |
 | Daniel Morganstern, M.D. Medical Oncologist Hartford HealthCare Cancer Institute Wethersfield, Connecticut |
 | Melissa L. Pilewskie, M.D., FACS Associate Attending, Breast Services Director, Strategic Planning and Research, RISE Program Memorial Sloan Kettering Cancer Center New York, New York |
 | Paul Sabbatini, M.D. Deputy Physician-in-Chief for Clinical Research Memorial Sloan Kettering Cancer Center New York, New York |
 | Harry Salinas, M.D. Chief of Breast Reconstruction Miami Cancer Institute Miami, Florida |
 | Ana Sandoval Leon, M.D. Breast Medical Oncologist Baptist Health Medical Group Miami, Florida |
 | Rachel Sanford, M.D. Medical Oncologist, Breast Cancer Breast Medicine Clinical Director Memorial Sloan Kettering Cancer Center New York, New York |
 | Kathy Jean Schilling, M.D. Medical Director Christine E. Lynn Women’s Health & Wellness Institute Boca Raton Regional Hospital Baptist Health South Florida Boca Raton, Florida |
 | Shannon N. Westin, M.D., MPH Associate Professor Director, Early Drug Development and Phase 1 Trials Department of Gynecologic Oncology and Reproductive Medicine UT MD Anderson Cancer Center, Houston, Texas |
 | Michael J. Zinner, M.D. Chief Executive Officer and Executive Medical Director Miami Cancer Institute Baptist Health South Florida Miami, Florida |
 | Oliver Zivanovic, M.D., Ph.D. Section, Ovarian Cancer Surgery Director, Innovative Surgical Technology Gynecology Service, Department of Surgery Memorial Sloan Kettering Cancer Center New York, New York |
Accreditation
Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
Baptist Health South Florida designates this live activity for a maximum of 6 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been approved for 6 credit hours, CE Broker Course #830244, by the Florida Boards of Medicine, Osteopathic Medicine, and by the Florida Council of Physician Assistants.
This activity has also been approved for 6 credits for Nursing, Occupational Therapy, Pharmacy, and Respiratory Care (personal growth). Baptist Health South Florida CE Broker Provider #50-182.
Disclaimer
Baptist Health South Florida presents this CME activity for use by healthcare professionals for educational purposes only. Opinions, perspectives and information presented by the faculty represent their ideas and views, and participants should carefully consider all available scientific data before acting on knowledge gained through this activity. Additionally, participants should consult the US Food and Drug Administration (FDA) for approved uses prior to prescribing medications or utilizing medical devices discussed in this activity.
While Baptist Health makes reasonable efforts to ensure that accurate information is presented, no warranty, expressed or implied, is offered. Participants should rely on their own clinical judgment, knowledge and experience before applying information acquired to their professional use.
Available Credit
- 6.00 AMA PRA Category 1 Credit™
- 6.00 General certificate of attendance
- 6.00 Nurse Practitioners
- 6.00 Florida Board of Nursing
- 6.00 Florida Board of Occupational Therapy
- 6.00 Florida Board of Pharmacy
- 6.00 Florida Board of Respiratory Therapy
The Miami Cancer Institute Women’s Cancer Symposium will be a fully virtual symposium, allowing learners to access high-quality content and engage remotely from around the world in a platform that has been designed explicitly for this meeting.
| Compatibility Notice | |
 | Google Chrome is recommended to access the live stream to ensure the best experience and optimal connectivity. NOTE: Live streaming is not compatible with Internet Explorer (IE). |